Orgenesis Inc. (ORGS)

Orgenesis Revenue

In the year 2024, Orgenesis had annual revenue of $1.04M with 95.28% growth. Orgenesis had revenue of $347.00K in the quarter ending September 30, 2024, with 215.45% growth. That makes Orgenesis the 43,556th largest company in the world by revenue and 6,089th in the United States.

• Revenue: 1.04M
• Revenue Growth: +95.28%
• P/S Ratio: 3.79
• Revenue / Employee: 13.44K
• Employees: 77
• Market Cap: 3.92M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Octomera 533.00K 50.4%
• Therapies 525.00K 49.6%

Fiscal year ended Dec 31, 2024 See the full Orgenesis breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.04M	505.00K	95.28%
Dec 31, 2023	530.00K	-35.50M	-98.53%
Dec 31, 2022	36.03M	523.00K	1.47%
Dec 31, 2021	35.50M	27.85M	363.96%
Dec 31, 2020	7.65M	3.75M	96.26%

Data Source: S&P Global Market Intelligence Last updated: Nov 13, 2024

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error